De Baere OLV SRL
1.0 FTEDe Baere OLV reported total assets of 269,784 € at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Jun 2026), with 1 full-time equivalent.
The score of De Baere OLV shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity +113 % Total assets -7 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
De Baere OLV's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Jun 2026
- Year ended 31 Dec 2024filed on 18 Jun 2025
- Year ended 31 Dec 2023filed on 15 May 2024
De Baere OLV's financial analysis
- Solvency34.5%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of De Baere OLV
De Baere OLV's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0793.872.546
- VAT number
- BE0793872546
- Peppol
- Registered · 0208:0793872546 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 23 Nov 2022
- Registered office
- 1760 Roosdaal
- Size
- Micro · 1.0 FTE
- Latest accounts
- 2025 · filed on 30 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
De Baere OLV (SRL) has been based in Roosdaal since 2022, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 2,247 € and equity of 93,136 €; its revenue is not published. With 1.0 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 34.5%, below the median of its sector (44.2%).
Companies similar to De Baere OLV
Companies in the same business, of comparable size and area, outside its group.
- Maxipharma Retail sale of pharmaceutical products Charleroi · balance sheet 269,211 €
- Pharm.Assy Retail sale of pharmaceutical products Wemmel · balance sheet 268,957 €
- Apotheek Haegemans - Mertens Retail sale of pharmaceutical products Herent · balance sheet 268,422 €
- Pharmacie Boden Retail sale of pharmaceutical products Seraing · balance sheet 267,278 €
- Gezondheidscentrum Vlierbeek Retail sale of pharmaceutical products Holsbeek · balance sheet 273,099 €
- Tripharma Retail sale of pharmaceutical products Molenbeek-Saint-Jean · balance sheet 266,344 €
- Pharmacy Ghent Retail sale of pharmaceutical products Ghent · balance sheet 273,292 €
- Oosterapotheek Retail sale of pharmaceutical products Antwerp · balance sheet 275,743 €
Frequently asked questions about De Baere OLV
What is the revenue of De Baere OLV?
De Baere OLV files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of De Baere OLV?
In Belgium, the VAT number is the company number prefixed with BE: BE0793872546 for De Baere OLV, if the company is VAT-registered. Its company number (CBE) is 0793.872.546.
Where is the registered office of De Baere OLV?
According to the CBE register, the registered office of De Baere OLV is in 1760 Roosdaal.
What is the equity of De Baere OLV?
At the close of the 2025 financial year, the equity of De Baere OLV amounts to 93,136 €, a solvency of 34.5% of total assets.
How many people work at De Baere OLV?
1.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages De Baere OLV?
The register lists 3 active mandates at De Baere OLV. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of De Baere OLV
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →